Evidence mapPaperPMID 27649641Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2017

Pharmacologically Induced Sex Hormone Fluctuation Effects on Resting-State Functional Connectivity in a Risk Model for Depression: A Randomized Trial.

Patrick MacDonald Fisher, Camilla Borgsted Larsen, Vincent Beliveau, Susanne Henningsson, Anja Pinborg, Klaus Kähler Holst, Peter Steen Jensen, Claus Svarer, Hartwig Roman Siebner, Gitte Moos Knudsen and 1 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Hormonal Cycle and Contraceptive Effects on Amygdala and Salience Resting-State Networks in Women with Previous Affective Side Effects on the Pill.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Sex differences and the neurobiology of affective disorders.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Patrick MacDonald FisherCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.ORCID 0000-0002-8115-0611
Camilla Borgsted LarsenCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.
Vincent BeliveauCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.
Susanne HenningssonCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.
Anja PinborgFaculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Klaus Kähler HolstDepartment of Biostatistics, University of Copenhagen, Copenhagen, Denmark.
Peter Steen JensenCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.
Claus SvarerCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.
Hartwig Roman SiebnerCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.
Gitte Moos KnudsenCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.
Vibe Gedsoe FrokjaerCenter for Integrated Molecular Brain Imaging, Copenhagen, Denmark.
Copenhagen University Hospital · DKUniversity of Copenhagen · DKHvidovre Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women are at relatively greater lifetime risk for depression than men. This elevated risk in women is partly due to heightened risk during time periods characterized by marked fluctuations in sex hormones, including postpartum and perimenopausal periods. How sex hormone fluctuations contribute to heightened risk is not fully understood but may involve intrinsic functional connectivity. We induced a biphasic ovarian sex hormone fluctuation using the gonadotropin-releasing hormone agonist (GnRHa) goserelin to determine, with a randomized placebo-controlled design, intervention effects on or GnRHa-provoked depressive symptoms associations with change in resting-state functional connectivity (rs-FC) in 58 healthy women for six seeds (amygdala, hippocampus, anterior cingulate cortex, dorsal raphe, median raphe, and posterior cingulate cortex). GnRHa intervention did not significantly affect rs-FC in any seeds. Considering the GnRHa group only, the emergence of depressive symptoms following intervention was positively associated with amygdala-right temporal cortex and negatively associated with hippocampus-cingulate rs-FC. A test for mediation suggested that rs-FC changes in these networks marginally mediated the association between decrease in estradiol and increase in depressive symptoms in the GnRHa group (p=0.07). Our findings provide novel evidence-linking changes in rs-FC networks, the emergence of depressive symptoms and sex hormone fluctuations. Notably, we observed evidence that changes in rs-FC may represent a key neurobiological intermediary between molecular changes induced by hormone fluctuations and the emergence of depressive symptoms. Taken together, our findings indicate that sex hormone fluctuations may contribute to heightened risk for developing depressive symptoms by affecting intrinsic functional connectivity of key limbic brain structures.

Indexed as

AdultBrainBrain MappingDepressionFemaleGonadal Steroid HormonesGonadotropin-Releasing HormoneGoserelinHumansMagnetic Resonance ImagingNeural PathwaysRisk FactorsYoung AdultGonadal Steroid HormonesGonadotropin-Releasing HormoneGoserelin

Identifiers

PMID27649641
PMCPMC5399242
OpenAlexW2438605488

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.